Drug intelligence / Profile preview

medical air equivalent

Development stage: Preclinical
Lead developer: University of Birmingham
Modality: Small Molecules
Administration: Inhalation

Overview

**Medical air equivalent** is an inhaled oxygen-nitrogen gas mixture used as the placebo comparator in the University of Birmingham OM-COPD crossover study, NCT01722370. Delivered from a cylinder at 2 liters per minute, it was formulated to mimic medical air without providing supplemental oxygen enrichment. It has no drug-specific biological target or pharmacologic mechanism and served to maintain blinding while evaluating ambulatory oxygen therapy for exertional hypoxia in chronic obstructive pulmonary disease.

Other names: oxygen-nitrogen mix equivalent to medical air

Beyond the preview

Go deeper on medical air equivalent.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on medical air equivalent.

Explore the full profile